M. Harnois

发表

Identification of five new genes, closely related to the interleukin-1beta converting enzyme gene, that do not encode functional proteases.

C. Rocher, F. Hervé, C. Faucheu, 1997, European journal of biochemistry.

Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer

Hyo Song Kim, Y. Bang, Jin-Hee Ahn, 2017, Oncotarget.

In Vivo Clearance of Tissue Plasminogen Activator: The Complex Role of Sites of Glycosylation and Level of Sialylation

D. Livingston, E. Nichols, L. Poisson, 1993 .

Crystal structures of two human pyrophosphorylase isoforms in complexes with UDPGlc(Gal)NAc: role of the alternatively spliced insert in the enzyme oligomeric assembly and active site architecture

P. Ferrari, Y. Bourne, Y Bourne, 2001, The EMBO journal.

A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification.

F. de Marinis, V. Moreno, A. Hollebecque, 2017, European journal of cancer.

TCT . 1 , a Target Molecule for-y / S T Cells , Is Encoded by an Immunoglobulin Superfamily Gene ( Blast-1 ) Located in the CD 1 Region of Human Chromosome 1 By

F. Mami-Chouaib, J. Dumas, T. Hercend, 2003 .

TCT.1, a target molecule for gamma/delta T cells, is encoded by an immunoglobulin superfamily gene (Blast-1) located in the CD1 region of human chromosome 1

F. Mami-Chouaib, P. Del Porto, J. Dumas, 1991, The Journal of experimental medicine.

Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer

Y. Bang, Jin-Hee Ahn, T. Kudo, 2017, Oncotarget.

Abstract A167: A phase I study of MET TKI SAR125844 in Asian patients (pts) with advanced solid tumors

Y. Bang, Tae Won Kim, D. Oh, 2015 .